<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beneri CA</submitter><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><pagination>93-100</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4928853</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Setting&lt;/h4>Standardized clinical case definitions represent the best option for pediatric tuberculosis (TB) disease diagnosis and classification.&lt;h4>Objective&lt;/h4>To apply published guidelines for intrathoracic TB classification for use in reporting diagnostic studies with passive case finding to presumed TB patients from International Maternal Pediatric Adolescent AIDS Clinical Trials P1041, a trial of isoniazid prophylaxis in healthy human immunodeficiency virus exposed, bacille Calmette-Guérin vaccinated infants which employed active surveillance to assess a novel application of these guidelines in this setting.&lt;h4>Methods&lt;/h4>P1041 presumed TB patients were retrospectively cross-classified by protocol-defined and National Institutes of Health (NIH) classifications, and agreement w</pubmed_abstract><journal>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</journal><pubmed_title>Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.</pubmed_title><pmcid>PMC4928853</pmcid><funding_grant_id>UM1 AI069456</funding_grant_id><funding_grant_id>M01 RR016587</funding_grant_id><funding_grant_id>UM1 AI068632</funding_grant_id><funding_grant_id>UM1 AI106716</funding_grant_id><funding_grant_id>UM1AI068616</funding_grant_id><funding_grant_id>UM1 AI068634</funding_grant_id><funding_grant_id>UM1AI106716</funding_grant_id><funding_grant_id>UM1 AI068616</funding_grant_id><funding_grant_id>UM1AI068632</funding_grant_id><funding_grant_id>HHSN272200800014C</funding_grant_id><funding_grant_id>UM1 AI069453</funding_grant_id><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Cotton MF</pubmed_authors><pubmed_authors>Madhi S</pubmed_authors><pubmed_authors>Beneri CA</pubmed_authors><pubmed_authors>Aaron L</pubmed_authors><pubmed_authors>Mitchell C</pubmed_authors><pubmed_authors>Violari A</pubmed_authors><pubmed_authors>P1041 team</pubmed_authors><pubmed_authors>Jean-Philippe P</pubmed_authors><pubmed_authors>Nachman S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.</name><description>&lt;h4>Setting&lt;/h4>Standardized clinical case definitions represent the best option for pediatric tuberculosis (TB) disease diagnosis and classification.&lt;h4>Objective&lt;/h4>To apply published guidelines for intrathoracic TB classification for use in reporting diagnostic studies with passive case finding to presumed TB patients from International Maternal Pediatric Adolescent AIDS Clinical Trials P1041, a trial of isoniazid prophylaxis in healthy human immunodeficiency virus exposed, bacille Calmette-Guérin vaccinated infants which employed active surveillance to assess a novel application of these guidelines in this setting.&lt;h4>Methods&lt;/h4>P1041 presumed TB patients were retrospectively cross-classified by protocol-defined and National Institutes of Health (NIH) classifications, and agreement w</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jan</publication><modification>2025-04-04T02:04:53.149Z</modification><creation>2019-03-27T02:17:18Z</creation></dates><accession>S-EPMC4928853</accession><cross_references><pubmed>26688534</pubmed><doi>10.5588/ijtld.14.0848</doi></cross_references></HashMap>